110 related articles for article (PubMed ID: 15491047)
21. Preparation and characterization of microparticles containing peptide produced by a novel process: spray freezing into liquid.
Yu Z; Rogers TL; Hu J; Johnston KP; Williams RO
Eur J Pharm Biopharm; 2002 Sep; 54(2):221-8. PubMed ID: 12191695
[TBL] [Abstract][Full Text] [Related]
22. Solid dispersions of itraconazole and enteric polymers made by ultra-rapid freezing.
Overhoff KA; Moreno A; Miller DA; Johnston KP; Williams RO
Int J Pharm; 2007 May; 336(1):122-32. PubMed ID: 17184938
[TBL] [Abstract][Full Text] [Related]
23. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
Dhumal RS; Shimpi SL; Paradkar AR
Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
[TBL] [Abstract][Full Text] [Related]
24. Stable high surface area lactate dehydrogenase particles produced by spray freezing into liquid nitrogen.
Engstrom JD; Simpson DT; Cloonan C; Lai ES; Williams RO; Barrie Kitto G; Johnston KP
Eur J Pharm Biopharm; 2007 Feb; 65(2):163-74. PubMed ID: 17027245
[TBL] [Abstract][Full Text] [Related]
25. Protection of hydrophobic amino acids against moisture-induced deterioration in the aerosolization performance of highly hygroscopic spray-dried powders.
Yu J; Chan HK; Gengenbach T; Denman JA
Eur J Pharm Biopharm; 2017 Oct; 119():224-234. PubMed ID: 28655664
[TBL] [Abstract][Full Text] [Related]
26. Protective effect of sodium stearate on the moisture-induced deterioration of hygroscopic spray-dried powders.
Yu J; Romeo MC; Cavallaro AA; Chan HK
Int J Pharm; 2018 Apr; 541(1-2):11-18. PubMed ID: 29454904
[TBL] [Abstract][Full Text] [Related]
27. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
[TBL] [Abstract][Full Text] [Related]
28. Investigation of the physical properties of spray-dried stabilised lysozyme particles.
Liao YH; Brown MB; Quader A; Martin GP
J Pharm Pharmacol; 2003 Sep; 55(9):1213-21. PubMed ID: 14604464
[TBL] [Abstract][Full Text] [Related]
29. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
Fini A; Cavallari C; Ospitali F
Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
[TBL] [Abstract][Full Text] [Related]
30. Solid-state amorphization of rebamipide and investigation on solubility and stability of the amorphous form.
Xiong X; Xu K; Li S; Tang P; Xiao Y; Li H
Drug Dev Ind Pharm; 2017 Feb; 43(2):283-292. PubMed ID: 27648489
[TBL] [Abstract][Full Text] [Related]
31. Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on Stability II: stability of a vaccine.
Abdul-Fattah AM; Truong-Le V; Yee L; Pan E; Ao Y; Kalonia DS; Pikal MJ
Pharm Res; 2007 Apr; 24(4):715-27. PubMed ID: 17372697
[TBL] [Abstract][Full Text] [Related]
32. Hot-melt extrusion for enhanced delivery of drug particles.
Miller DA; McConville JT; Yang W; Williams RO; McGinity JW
J Pharm Sci; 2007 Feb; 96(2):361-76. PubMed ID: 17075869
[TBL] [Abstract][Full Text] [Related]
33. Spray freezing into liquid versus spray-freeze drying: influence of atomization on protein aggregation and biological activity.
Yu Z; Johnston KP; Williams RO
Eur J Pharm Sci; 2006 Jan; 27(1):9-18. PubMed ID: 16188431
[TBL] [Abstract][Full Text] [Related]
34. Characterization of glass solutions of poorly water-soluble drugs produced by melt extrusion with hydrophilic amorphous polymers.
Forster A; Hempenstall J; Rades T
J Pharm Pharmacol; 2001 Mar; 53(3):303-15. PubMed ID: 11291745
[TBL] [Abstract][Full Text] [Related]
35. Crystal growth formation in melt extrudates.
Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
[TBL] [Abstract][Full Text] [Related]
36. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
[TBL] [Abstract][Full Text] [Related]
37. Rapid dissolution of high-potency danazol particles produced by evaporative precipitation into aqueous solution.
Chen X; Vaughn JM; Yacaman MJ; Williams RO; Johnston KP
J Pharm Sci; 2004 Jul; 93(7):1867-78. PubMed ID: 15176074
[TBL] [Abstract][Full Text] [Related]
38. Investigation of the effects of grinding and co-grinding on physicochemical properties of glisentide.
Mura P; Cirri M; Faucci MT; Ginès-Dorado JM; Bettinetti GP
J Pharm Biomed Anal; 2002 Sep; 30(2):227-37. PubMed ID: 12191707
[TBL] [Abstract][Full Text] [Related]
39. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
[TBL] [Abstract][Full Text] [Related]
40. Effect of a melt agglomeration process on agglomerates containing solid dispersions.
Vilhelmsen T; Eliasen H; Schaefer T
Int J Pharm; 2005 Oct; 303(1-2):132-42. PubMed ID: 16139973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
